Cargando…

Nanomodulation of Macrophages in Multiple Sclerosis

Multiple Sclerosis (MS) is a chronic demyelinating autoimmune disease primarily affecting young adults. Despite an unclear causal factor, symptoms and pathology arise from the infiltration of peripheral immune cells across the blood brain barrier. Accounting for the largest fraction of this infiltra...

Descripción completa

Detalles Bibliográficos
Autores principales: Nally, Frances K., De Santi, Chiara, McCoy, Claire E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6628349/
https://www.ncbi.nlm.nih.gov/pubmed/31195710
http://dx.doi.org/10.3390/cells8060543
_version_ 1783434939168980992
author Nally, Frances K.
De Santi, Chiara
McCoy, Claire E.
author_facet Nally, Frances K.
De Santi, Chiara
McCoy, Claire E.
author_sort Nally, Frances K.
collection PubMed
description Multiple Sclerosis (MS) is a chronic demyelinating autoimmune disease primarily affecting young adults. Despite an unclear causal factor, symptoms and pathology arise from the infiltration of peripheral immune cells across the blood brain barrier. Accounting for the largest fraction of this infiltrate, macrophages are functionally heterogeneous innate immune cells capable of adopting either a pro or an anti-inflammatory phenotype, a phenomenon dependent upon cytokine milieu in the CNS. This functional plasticity is of key relevance in MS, where the pro-inflammatory state dominates the early stage, instructing demyelination and axonal loss while the later anti-inflammatory state holds a key role in promoting tissue repair and regeneration in later remission. This review highlights a potential therapeutic benefit of modulating macrophage polarisation to harness the anti-inflammatory and reparative state in MS. Here, we outline the role of macrophages in MS and look at the role of current FDA approved therapeutics in macrophage polarisation. Moreover, we explore the potential of particulate carriers as a novel strategy to manipulate polarisation states in macrophages, whilst examining how optimising macrophage uptake via nanoparticle size and functionalisation could offer a novel therapeutic approach for MS.
format Online
Article
Text
id pubmed-6628349
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-66283492019-07-23 Nanomodulation of Macrophages in Multiple Sclerosis Nally, Frances K. De Santi, Chiara McCoy, Claire E. Cells Review Multiple Sclerosis (MS) is a chronic demyelinating autoimmune disease primarily affecting young adults. Despite an unclear causal factor, symptoms and pathology arise from the infiltration of peripheral immune cells across the blood brain barrier. Accounting for the largest fraction of this infiltrate, macrophages are functionally heterogeneous innate immune cells capable of adopting either a pro or an anti-inflammatory phenotype, a phenomenon dependent upon cytokine milieu in the CNS. This functional plasticity is of key relevance in MS, where the pro-inflammatory state dominates the early stage, instructing demyelination and axonal loss while the later anti-inflammatory state holds a key role in promoting tissue repair and regeneration in later remission. This review highlights a potential therapeutic benefit of modulating macrophage polarisation to harness the anti-inflammatory and reparative state in MS. Here, we outline the role of macrophages in MS and look at the role of current FDA approved therapeutics in macrophage polarisation. Moreover, we explore the potential of particulate carriers as a novel strategy to manipulate polarisation states in macrophages, whilst examining how optimising macrophage uptake via nanoparticle size and functionalisation could offer a novel therapeutic approach for MS. MDPI 2019-06-05 /pmc/articles/PMC6628349/ /pubmed/31195710 http://dx.doi.org/10.3390/cells8060543 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Nally, Frances K.
De Santi, Chiara
McCoy, Claire E.
Nanomodulation of Macrophages in Multiple Sclerosis
title Nanomodulation of Macrophages in Multiple Sclerosis
title_full Nanomodulation of Macrophages in Multiple Sclerosis
title_fullStr Nanomodulation of Macrophages in Multiple Sclerosis
title_full_unstemmed Nanomodulation of Macrophages in Multiple Sclerosis
title_short Nanomodulation of Macrophages in Multiple Sclerosis
title_sort nanomodulation of macrophages in multiple sclerosis
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6628349/
https://www.ncbi.nlm.nih.gov/pubmed/31195710
http://dx.doi.org/10.3390/cells8060543
work_keys_str_mv AT nallyfrancesk nanomodulationofmacrophagesinmultiplesclerosis
AT desantichiara nanomodulationofmacrophagesinmultiplesclerosis
AT mccoyclairee nanomodulationofmacrophagesinmultiplesclerosis